Dr. Thomas E. Waggoner I, DO

Dr. Waggoner practices at Pima Heart & Vascular in Tucson, Arizona.

Dr. Waggoner's NPI, 1891083812, was assigned on July 11, 2011. Dr. Waggoner graduated from University of New England, College of Osteo Medicine in 2008. Dr. Waggoner holds Arizona license 006643.

Dr. Waggoner's primary practice is Pima Heart & Vascular, at 3709 N Campbell Ave, Tucson, AZ 85719 in Pima County. The practice phone is (520) 838-3540.

Dr. Waggoner's primary practice is Pima Heart & Vascular in Tucson, Arizona. Dr. Waggoner is also affiliated with Tucson Medical Center. The medical group on file is Pima Heart & Vascular. Dmand AI also links Dr. Waggoner to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Waggoner practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Waggoner's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Waggoner's licenses on file in 3 states: Arizona, Florida and New Jersey.

CMS data shows 7,602 Medicare services from Dr. Waggoner across 33 procedure codes in 2024, for 769 Medicare patients. Medicare paid $353,606 for them.

CMS counts 769 Medicare patients who saw Dr. Waggoner in 2024. The largest group is 75 to 84, with 353 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Waggoner's median patient age at 79, with 47% women.

In 2024, Dr. Waggoner wrote 1,690 Medicare Part D claims for 435 patients. 84% of them were for generic drugs. CMS names the drug for 1,495 of them, across 27 drugs with 11 or more claims each, at $299,280 in total drug cost. In 2023, CMS named 1,468 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Waggoner for performance year 2024, reported as part of a group. Dr. Waggoner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Waggoner as offering telehealth. CMS counts 23 procedures of coronary angioplasty and stenting by Dr. Waggoner, more than 55% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Waggoner, published from 2015 to 2025. 2022 was the busiest year, with 2. The most frequent topics are Aortic Valve, Aortic Valve Stenosis and Heart Valve Prosthesis. Dr. Waggoner has published most often in J Soc Cardiovasc Angiogr Interv. Dr. Waggoner's most frequent co-authors are Amr E. Abbas, MD, Karim Mohamed Al-Azizi, MD and Anthony A. Bavry, MD.

Dmand AI links Dr. Waggoner to 9 clinical trials. 7 are still active or recruiting. Conditions studied include Angina, Stable, Aortic Valve Insufficiency and Atrial Fibrillation. Boston Scientific Corporation sponsors the most, 4.

CMS Open Payments shows 1,759 general payments to Dr. Waggoner from 53 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 39% of the total. Boston Scientific Corporation paid the most, $267,060. It also lists 3 research payments totaling $263 in 2023.

Dr. Waggoner graduated from University of New England, College of Osteo Medicine in 2008.